Study to Assess the Safety, Tolerance and Efficacy of Tezampanel in Patients With Acute Migraine

NCT00567086 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

306

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: TEZAMPANEL

Sponsor

TorreyPines Therapeutics